Published in Vaccine Weekly, April 2nd, 2008
"The articles that were included in this review reported antibody levels >= 4 months after influenza immunization in persons >= 60 years old, interpretable in the context of annual influenza vaccine-approval criteria (seroprotection/seroconversion) specified by the Committee for Proprietary Medicinal Products (CPMP) for the elderly. The final review included 14 studies; 8...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly